跳至主要内容
临床试验/ACTRN12607000653460
ACTRN12607000653460已完成未知

The Remineralization of Subsurface Enamel Carious Lesions in situ by Casein Phosphopeptide-Amorphous Calcium Phosphate (CPP-ACP) and 900 ppm fluoride in Tooth Mousse Plus™, and 5000 ppm fluoride in Neutrafluor 5000™

The University of Melbourne0 个研究点目标入组 5 人开始时间: 2007年12月20日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
5

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 60 Years(—)
性别
All

入选标准

  • Adults in good general and dental health
  • Have at least 22 teeth
  • Produce normal amounts of saliva (determined by measuring the volume of a two-minute unstimulated saliva sample and a two-minute stimulated saliva sample).

排除标准

  • Allergic or adverse reactions to milk or milk products.
  • History of dry mouth, or medical conditions or taking medication likely to cause xerostomia.
  • Bleeding disorders.
  • Infectious diseases including blood-borne diseases such as HIV/AIDS; or Hepatitis C.
  • Active dental caries or periodontal diseases.
  • History of rheumatic heart disease, heart murmurs, etc. where risk of complications following bacteremia is present.

研究者

相似试验